Clinical Case Reports (Jul 2021)

Successful treatment of critical coronavirus disease 2019 in a patient with lung cancer concomitant with pembrolizumab‐induced arthritis by methylprednisolone, baricitinib, and remdesivir

  • Naohiro Oda,
  • Keiji Miyoshi,
  • Daisuke Morichika,
  • Yuka Beika,
  • Takahiro Taki,
  • Reo Mitani,
  • Toshiaki Okada,
  • Ichiro Takata

DOI
https://doi.org/10.1002/ccr3.4459
Journal volume & issue
Vol. 9, no. 7
pp. n/a – n/a

Abstract

Read online

Abstract COVID‐19 in cancer patients on immunosuppressive agents for the treatment of immune‐related adverse events of immune checkpoint inhibitors can rapidly deteriorate. The combination therapy with methylprednisolone, baricitinib, and remdesivir may be effective for critical COVID‐19, and further clinical trials are warranted.

Keywords